Jul 2 |
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
|
Jun 18 |
Compelling Reasons to Hold on to Cigna Stock for Now
|
Jun 5 |
Here's Why You Should Consider Buying Bioventus (BVS) Stock
|
Jun 5 |
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
|
May 31 |
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
|
May 30 |
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
|
May 29 |
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
|
May 23 |
3 Stocks Under $10 With Mammoth Growth Prospects
|
May 8 |
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript
|
May 8 |
Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ...
|